Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Tretinoin - Generic Drug Details

« Back to Dashboard

What are the generic sources for tretinoin and what is the scope of tretinoin patent protection?

Tretinoin
is the generic ingredient in eight branded drugs marketed by Mylan, Mylan Pharms Inc, Valeant Pharms North, Allergan Sales Llc, Perrigo Pharma Intl, Valeant Intl, Valeant Bermuda, Spear Pharms Inc, Roche, Wockhardt, Dow Pharm, Teva Pharms, Glenmark Generics, Barr Labs Inc, Anchen Pharms, and Zo Skin Health, and is included in twenty-nine NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Tretinoin has nineteen patent family members in nine countries.

There are twenty-four drug master file entries for tretinoin. Twenty-seven suppliers are listed for this compound.

Summary for Generic Name: tretinoin

Tradenames:8
Patents:3
Applicants:16
NDAs:29
Drug Master File Entries: see list24
Suppliers / Packagers: see list27
Bulk Api Vendors: see list93
Clinical Trials: see list40
Patent Applications: see list9,907
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tretinoin at DailyMed

Pharmacology for Ingredient: tretinoin

Ingredient-typeRetinoids
Drug ClassRetinoid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Intl
RETIN-A
tretinoin
GEL;TOPICAL017579-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Perrigo Pharma Intl
TRETINOIN
tretinoin
CREAM;TOPICAL075264-001Dec 24, 1998ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
TRETINOIN
tretinoin
CAPSULE;ORAL208279-001Dec 23, 2016ABRXNoNo► Subscribe► Subscribe
Allergan Sales Llc
TRETINOIN
tretinoin
CREAM;TOPICAL202209-001Oct 11, 2012DISCNNoNo► Subscribe► Subscribe
Dow Pharm
ATRALIN
tretinoin
GEL;TOPICAL022070-001Jul 26, 2007ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot